Clinical Trials Directory

Trials / Completed

CompletedNCT00898417

Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab

Development of a Serum Proteomic Classifier for the Prediction of Benefit From Bevacizumab in Combination With Carboplatin and Paclitaxel

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
ECOG-ACRIN Cancer Research Group · Network
Sex
All
Age
18 Years – 120 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Studying samples of blood in the laboratory from patients undergoing treatment for non-small cell lung cancer may help doctors predict how patients will respond to treatment. PURPOSE: This laboratory study is looking at proteomic patterns in stored blood samples from patients undergoing treatment for non-small cell lung cancer.

Detailed description

OBJECTIVES: Primary * To develop a serum proteomic classifier using matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry analysis of blood samples from patients with non-squamous cell non-small cell lung cancer to predict benefit, in terms of survival and time to progression, from treatment with bevacizumab in combination with carboplatin and paclitaxel. Secondary * To better quantitate candidate biomarkers by using more advanced mass spectrometric technologies, including multiple-reaction monitoring and heavy-labeled peptides. OUTLINE: Previously collected pre-treatment samples of serum or plasma are randomly selected from patients enrolled on protocol ECOG-4599 (i.e., 60 from the bevacizumab arm and 30 from the control arm). Samples are analyzed by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry to identify patterns from protein spectra that correlate with patient survival.

Conditions

Interventions

TypeNameDescription
BIOLOGICALbevacizumab
DRUGcarboplatin
DRUGpaclitaxel
GENETICproteomic profiling
OTHERlaboratory biomarker analysis
OTHERmatrix-assisted laser desorption/ionization time of flight mass spectrometry

Timeline

Start date
2008-03-14
Primary completion
2008-04-14
Completion
2008-04-14
First posted
2009-05-12
Last updated
2017-05-19

Source: ClinicalTrials.gov record NCT00898417. Inclusion in this directory is not an endorsement.